Our European footprint, R&D and manufacturing sites in Europe

Lilly is a medicines company with over 43,000 employees worldwide, including more than 9,000 in Europe. One of five (23,8%) employees is active in R&D. 27.3% of sales is reinvested in R&D, representing ~9313Million US$ in 2023. Clinical research is performed in 55 different countries.

In addition to commercial activities that span the whole of Europe, we have a considerable R&D and manufacturing presence located across five countries in Europe, as well as nine beyond.

Alcobendas, Spain (since 1968); Fegersheim, France (since 1967); Kinsale (since 1981) and Limerick (since 2022), Ireland; Sesto Fiorentino, Italy (since 1959) and Alzey, Germany (since 2023).

Alcobendas, Spain
More information can be found here.

Fegersheim, France
More information can be found here.

Kinsale, Ireland
More information can be found here.

Sesto Fiorentino, Italy
More information can be found here.